Semaglutide: Review and Place in Therapy for Adults With Type 2 Diabetes.
Sign Up to like & getrecommendations! Published in 2019 at "Canadian journal of diabetes"
DOI: 10.1016/j.jcjd.2018.05.008
Abstract: Guidelines increasingly highlight the importance of multifactorial management in type 2 diabetes, in contrast to the more traditional focus on glycemic control. Semaglutide, a recently approved glucagon-like peptide-1 receptor agonist, is indicated in Canada for… read more here.
Keywords: diabetes semaglutide; type diabetes; phase trials; place ... See more keywords